Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
688336
Rang in aandelen
#3772
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Aandeelprijs
$4.87
Marktkapitalisatie
$4.36B
Verandering (1 dag)
-5.47%
Verandering (1 jaar)
-15.62%
Land
CN
Handel Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Categorie
Healthcare
Dividendgeschiedenis van Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (aandelsymbool: 688336) heeft in totaal 5 dividenduitkeringen gedaan.
De som van alle dividenden (aangepast voor aandelensplitsingen) is: $0.63
Dividendrendement (TTM): 0.0149
De som van alle dividenden (aangepast voor aandelensplitsingen) is: $0.63
Dividendrendement (TTM): 0.0149
Dividendbetalingen voor Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336) van 2024 tot 2026
Jaarlijkse dividendbetalingen
| Jaar | Dividend (aangepast voor aandelensplitsingen) | Wijzigen |
|---|---|---|
| 2026 (TTM) | $0.45 | 265.85% |
| 2025 | $0.123 | 114.66% |
| 2024 | $0.0573 | 0.00% |
Lijst van alle dividendbetalingen
| Jaar | Dividend | Wijzigen |
|---|---|---|
| 2026 (TTM) | $0.6525 | 265.75% |
| 2025 | $0.1784 | 114.94% |
| 2024 | $0.083 | 0.00% |
Dividendbetalingen voor vergelijkbare bedrijven of concurrenten
| Bedrijf | Aantal dividendbetalingen | Land |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 30.00% |
BE
|
|
| 0.00% |
NL
|
